Ann TuckerMar 31, 20231 min readSAMHSA Warns of Growing Threat from XylazineSAMHSA [3/27] | In a letter to clinicians, SAMHSA wrote that xylazine is an emerging public health threat and noted that routine toxicology tests do not test for the substance. Cont.
SAMHSA [3/27] | In a letter to clinicians, SAMHSA wrote that xylazine is an emerging public health threat and noted that routine toxicology tests do not test for the substance. Cont.
New Mental Health Rule Introduces Employer Benefit Parity TestBloomberg Government [9/09] - The Biden administration is poised to issue a final rule toughening mandates for employer-sponsored health...
Sackler Family Risks Litigation After Supreme Court Rejects Purdue Pharma SettlementForbes [7/09] - Purdue Pharma went back to court this week after the Supreme Court thwarted the OxyContin maker’s...
Comments